283 related articles for article (PubMed ID: 33324682)
1. Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment.
Wu Z; Zhang Y; Chen X; Tan W; He L; Peng L
Front Mol Biosci; 2020; 7():601206. PubMed ID: 33324682
[No Abstract] [Full Text] [Related]
2. Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values.
Hu LT; Deng WJ; Chu ZS; Sun L; Zhang CB; Lu SZ; Weng JR; Ren QS; Dong XY; Li WD; Li XB; Du YT; Li Y; Wang WQ
BMC Pulm Med; 2022 Jun; 22(1):259. PubMed ID: 35768814
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.
Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z
Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.
Zhang C; Cui Y; Wang G; Zhao W; Zhao H; Huang X; Zhang M; Li W
J Healthc Eng; 2021; 2021():5790416. PubMed ID: 34531966
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the prognostic values of CXCR family in gastric cancer.
Yu C; Zhang Y
Cytokine; 2019 Nov; 123():154785. PubMed ID: 31344595
[TBL] [Abstract][Full Text] [Related]
7. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis.
Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
[TBL] [Abstract][Full Text] [Related]
8. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma.
Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J
Front Immunol; 2023; 14():1102824. PubMed ID: 37122750
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the prognostic value of
Chen J; Ye Z; Liu L; Xuan B
Transl Androl Urol; 2022 Apr; 11(4):509-518. PubMed ID: 35558273
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of sirtuin family members and experimental verification identify SIRT5 as diagnostic biomarkers in clear cell renal cell carcinoma.
Peng LS; Duan SL; Li RQ; Bai ZY; Ou CL; Wang JP
PeerJ; 2023; 11():e15154. PubMed ID: 37096064
[TBL] [Abstract][Full Text] [Related]
11. Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma.
Guo H; Jiang S; Sun H; Shi B; Li Y; Zhou N; Zhang D; Guo H
Dis Markers; 2022; 2022():9443407. PubMed ID: 35299868
[TBL] [Abstract][Full Text] [Related]
12. Effect of MAP3K8 on Prognosis and Tumor-Related Inflammation in Renal Clear Cell Carcinoma.
Hao J; Cao Y; Yu H; Zong L; An R; Xue Y
Front Genet; 2021; 12():674613. PubMed ID: 34567061
[No Abstract] [Full Text] [Related]
13. Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma.
Shen Y; Zhou C; Cao Y; Li Q; Deng H; Gu S; Wu Y; Shen Z
World J Surg Oncol; 2022 Aug; 20(1):259. PubMed ID: 35978426
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma.
Zhu Y; Pu Z; Li Z; Lin Y; Li N; Peng F
Front Oncol; 2021; 11():700528. PubMed ID: 34395271
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive exploration of the expression and prognostic value of AQPs in clear cell renal cell carcinoma.
Wang H; Zhang W; Ding Z; Xu T; Zhang X; Xu K
Medicine (Baltimore); 2022 Oct; 101(41):e29344. PubMed ID: 36254092
[TBL] [Abstract][Full Text] [Related]
16. Systematic Analysis of the Expression and Prognosis of Fcγ Receptors in Clear Cell Renal Cell Carcinoma.
Nie W; Yao Y; Luo B; Zhu J; Li S; Yang X; Luo T; Liu W; Yan S
Front Oncol; 2022; 12():755936. PubMed ID: 35372055
[TBL] [Abstract][Full Text] [Related]
17. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction.
Sun Y; Yang M; Zhang Q
Ann Transl Med; 2022 Dec; 10(24):1379. PubMed ID: 36660642
[TBL] [Abstract][Full Text] [Related]
18. GSDMB: A novel, independent prognostic marker and potential new therapeutic target in clear cell renal cell carcinoma.
Huang H; Chen R; Deng X; Wang J; Chen J
Oncol Lett; 2024 Feb; 27(2):85. PubMed ID: 38249806
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression and the significant prognostic value of aquaporins in clear cell renal cell carcinoma.
Li M; He M; Xu F; Guan Y; Tian J; Wan Z; Zhou H; Gao M; Chong T
PLoS One; 2022; 17(3):e0264553. PubMed ID: 35245343
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
Front Genet; 2020; 11():810. PubMed ID: 33014010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]